Liver Health

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

d-alpha-tocopheryl acid succinate, Quantity: 1.37 mg; Taraxacum officinale, Quantity: 66.6 mg (Equivalent: Taraxacum officinale, Qty 333 mg); ascorbic acid, Quantity: 40 mg; Brassica oleracea var. italica, Quantity: 250 mg; alpha lipoic acid, Quantity: 50 mg; Silybum marianum, Quantity: 28.57 mg (Equivalent: Silybum marianum, Qty 1999.9 mg; Equivalent: Flavanolignans calculated as silybin, Qty 23.9988 mg); betacarotene, Quantity: 0.8782 mg

Commercializzato da:

Modere Australia Pty Ltd

INN (Nome Internazionale):

alpha lipoic acid,Ascorbic acid,Betacarotene,Brassica oleracea var. italica,d-alpha-Tocopheryl acid succinate,Silybum marianum,T

Forma farmaceutica:

Tablet, film coated

Composizione:

Excipient Ingredients: silicon dioxide; microcrystalline cellulose; hypromellose; Carnauba Wax; calcium hydrogen phosphate dihydrate; magnesium stearate; ethylcellulose; povidone; crospovidone; starch sodium octenyl succinate; purified water; dl-alpha-tocopherol; glucose monohydrate; dextrin; carmellose sodium; sodium citrate dihydrate; lecithin

Via di somministrazione:

Oral

Indicazioni terapeutiche:

Antioxidant/Reduce free radicals formed in the body ; Helps reduce/decrease free radical damage to body cells ; Traditionally used in Western herbal medicine to Maintain/support natural liver cleansing/detoxification processes ; Maintain/support general health and wellbeing ; Traditionally used in Western herbal medicine to Helps maintain/support bile secretion/flow ; Maintain/support liver health ; Traditionally used in Western herbal medicine to Maintain/support liver health

Dettagli prodotto:

Visual Identification: ;

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2015-04-09